Related Experiment Video
Updated: Aug 9, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Mitoferrin-1 Promotes Proliferation and Abrogates Protein Oxidation via the Glutathione Pathway in Glioblastoma
Md Yousuf Ali1, Corinne E Griguer1,2, Susanne Flor1,2
1Interdisciplinary Graduate Program in Human Toxicology, The University of Iowa, Iowa City, IA 52242, USA.
Abstract:
Median overall survival is very low in patients with glioblastoma (GBM), largely because these tumors become resistant to therapy. Recently, we found that a decrease in the cytosolic labile iron pool underlies the acquisition of radioresistance. Both cytosolic and mitochondrial iron are important for regulating ROS production, which largely facilitates tumor progression and response to therapy. Here, we investigated the role of the mitochondrial iron transporters mitoferrin-1 (MFRN1) and mitoferrin-2 (MFRN2) in GBM progression. Analysis of The Cancer Genome Atlas database revealed upregulation of MFRN1 mRNA and downregulation of MFRN2 mRNA in GBM tumor tissue compared with non-GBM tissue, yet only the tumor expression level of MFRN1 mRNA negatively correlated with overall survival in patients. Overexpression of MFRN1 in glioma cells significantly increased the level of mitochondrial iron, enhanced the proliferation rate and anchorage-independent growth of these cells, and significantly decreased mouse survival in an orthotopic model of glioma. Finally, MFRN1 overexpression stimulated the upregulation of glutathione, which protected glioma cells from 4-hydroxynonenal-induced protein damage. Overall, these results demonstrate a mechanistic link between MFRN1-mediated mitochondrial iron metabolism and GBM progression. Manipulation of MFRN1 may provide a new therapeutic strategy for improving clinical outcomes in patients with GBM.
Insights
Mitochondrial iron transporter MFRN1 promotes glioblastoma (GBM) progression by increasing mitochondrial iron and glutathione levels. Targeting MFRN1 may offer a new therapeutic strategy for GBM patients.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Glioblastoma (GBM) exhibits poor patient survival due to therapeutic resistance.
- Cytosolic labile iron pool reduction is linked to radioresistance.
- Iron metabolism, particularly mitochondrial iron, influences reactive oxygen species (ROS) production, tumor progression, and therapy response.
Purpose of the Study:
- Investigate the role of mitochondrial iron transporters mitoferrin-1 (MFRN1) and mitoferrin-2 (MFRN2) in GBM progression.
- Determine the correlation between MFRN1/MFRN2 expression and patient survival.
- Elucidate the mechanistic link between MFRN1 and GBM aggressiveness.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) database for MFRN1 and MFRN2 mRNA expression in GBM.
- Overexpression of MFRN1 in glioma cells.
- Assessment of mitochondrial iron levels, cell proliferation, and anchorage-independent growth.
- Evaluation of mouse survival in an orthotopic glioma model.
- Measurement of glutathione levels and protein damage.
Main Results:
- GBM tissue shows increased MFRN1 mRNA and decreased MFRN2 mRNA compared to non-GBM tissue.
- Higher MFRN1 mRNA levels correlate with reduced overall survival in GBM patients.
- MFRN1 overexpression in glioma cells increases mitochondrial iron, enhances proliferation and anchorage-independent growth, and decreases survival in mice.
- MFRN1 overexpression upregulates glutathione, conferring protection against protein damage.
Conclusions:
- Mitochondrial iron transporter MFRN1 plays a crucial role in GBM progression.
- MFRN1-mediated mitochondrial iron metabolism is mechanistically linked to GBM aggressiveness.
- Targeting MFRN1 presents a potential therapeutic strategy to improve outcomes for GBM patients.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway

